Clinical Trial

Giant Cell Arteritis - Ways to Precision Medicine

Recruiting
View on ClinicalTrials.gov →
Summary
Long-term follow-up of aortal adverse events, as well as glucocortioid-associated adverse events in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-16; most recent amendment 2025-12-15.
Status change: Not Yet Recruiting → Recruiting 2025-12-15
Trial Details
NCT Number NCT07084480
Lead Sponsor Wuerzburg University Hospital
Conditions Giant Cell Arteritis, Polymyalgia Rheumatic (PMR)
Enrollment 400 participants
Start Date 2025-11-14
Primary Completion 2030-07-31 (estimated)
Study Completion 2033-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-22